Bioactive Compounds
-
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor -
A1745 Galanthamine HBrSummary: Acetylcholinesterase inhibitor -
A1623 Epothilone ASummary: Microtubule stabilizing macrolide -
A2065 IC-87114Summary: PI3Kδ inhibitor -
A1602 Dexrazoxane HCl (ICRF-187, ADR-529)Target: TopoisomerasesSummary: Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent -
A2133 Saracatinib (AZD0530)3 CitationTarget: SrcSummary: Src/Abl inhibitor,potent and selective -
A5384 ZileutonSummary: 5-lipoxygenase (5-LOX) inhibitor, orally active -
A5183 ClopidogrelTarget: P2Y ReceptorsSummary: P2Y12 receptor antagonist -
A5790 CidofovirTarget: CMVSummary: Anti-CMV drug;inhibitor of viral DNA syntheis -
A5979 Tie2 kinase inhibitor1 CitationTarget: Tie-2Summary: Tie-2(Tie2 ) inhibitor

